Paul B. Manning - Jul 27, 2021 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Director
Signature
/s/ John Canepa, Attorney-in-Fact
Stock symbol
CADL
Transactions as of
Jul 27, 2021
Transactions value $
$410,778
Form type
4
Date filed
7/29/2021, 09:02 PM
Previous filing
Jul 26, 2021
Next filing
Aug 4, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CADL Common Stock Purchase $265K +36K $7.36* 36K Jul 27, 2021 Direct F1, F2
transaction CADL Common Stock Purchase $146K +20K +55.56% $7.30* 56K Jul 29, 2021 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $7.31 to $7.40. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
F2 Shares held jointly with spouse.
F3 The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $6.855 to $7.80. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.

Remarks:

Exhibit 24 - Power of Attorney